Aligos Therapeutics, Inc. ALGS

5.51 (0.04) (0.72%) as of 25 Sep
Market cap
$32.6M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments
30.42 55.08 77.95 99.21

+8 more quarters

Receivables
27.78 — — —
Other current assets
3.93 4.55 4.91 4.23
Total current assets
62.13 59.63 82.86 103.44
Property, Plant, Equpment (Net)
1.33 1.59 1.87 2.04
Long-term assets (Other)
0.76 0.76 0.72 0.71
Total non-current assets
4.20 4.93 5.67 6.33
Total Assets
66.33 64.56 88.53 109.76
Accounts Payable
6.43 7.64 3.98 4.65
Accrued Expenses
18.70 11.99 13.53 13.61
Current Part of Capital Lease
0.06 0.08 0.15 0.02
Current Revenue (Deferred)
— — — 0.17
Total current liabilities
28.34 23.32 21.23 21.99
Long Term Debt (Total)
— — — 0.12
Non-current Liabilities (Other)
5.81 8.79 12.23 13.44
Total non-current liabilities
6.10 9.45 13.76 15.94
Total liabilities
34.44 32.77 34.99 37.93
Additional Paid In Capital
698.18 696.58 695.27 693.69
Common Stock (Net)
0.01 0.01 0.01 0.01
Retained Earnings
(666.74) (665.24) (642.20) (622.32)
Common Equity (Total)
31.88 31.79 53.55 71.83
Shareholders Equity (Total)
31.88 31.79 53.55 71.83
Shareholders Equity and Liabilities (Total)
66.33 64.56 88.53 109.76
Shares (Common)
6.24 6.19 6.18 6.15
Shareholders Equity (Tangible)
31.88 31.79 53.55 71.83
Net Debt
(30.42) (55.08) (77.95) (99.08)
Total Debt
— — — 0.12

Fold the line items

In millions of $ except per-share values · columns are period end dates